Vidadi M. Yusibov, PhD
Director, Research Programs and Senior Research Fellow
Vidadi Yusibov, Ph.D., is a science-focused executive with more than 15 years of operational and strategic leadership experience in biopharmaceutical R&D and business development, with particular focus on vaccines and therapeutics. At IBRI his responsibilities will include expanding and strengthening IBRI’s core capabilities in Pharmaceutical Biotechnology through building and managing a cross-functional matrix organization, developing translational research programs and establishing partnerships.
Prior to joining the IBRI he was the Scientific Director and then the Executive Director of the Fraunhofer USA Center for Molecular Biotechnology where he developed strategic plans and led the growth of a unique translational research organization, secured more than $150 million from public and private institutions. He established multiple partnerships involving academia, industry and federal institutions. Furthermore, Dr. Yusibov worked extensively with local and federal legislators, economic development authorities and agencies to better align developments at the Center with regulatory guidelines and market needs.
In his academic career, Dr. Yusibov was an Assistant Professor at Thomas Jefferson University in Philadelphia after holding research positions at Purdue University in Lafayette, Indiana. His research has focused on the development and application of new technologies for vaccine and therapeutics development.
He earned his Ph.D. in Molecular Biology at the Academy of Sciences in Moscow, Russia and his M.S. in Plant Biochemistry and his B.A. in Biology at St. Petersburg University in St. Petersburg, Russia. As the developer of new technology for human health applications, he initiated and led a conference series known as “New Technologies, New Vaccines” that became a place for the exchange of new knowledge and ideas for the scientific community and regulatory authorities.